These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7902055)

  • 1. In vivo detection of neurotransmitter changes in Alzheimer's disease.
    Nordberg A
    Ann N Y Acad Sci; 1993 Sep; 695():27-33. PubMed ID: 7902055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.
    Nordberg A; Lundqvist H; Hartvig P; Andersson J; Johansson M; Hellstrŏm-Lindahi E; Långström B
    Dement Geriatr Cogn Disord; 1997; 8(2):78-84. PubMed ID: 9065319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies in Alzheimer patients with positron emission tomography.
    Nordberg A
    Behav Brain Res; 1993 Nov; 57(2):215-24. PubMed ID: 7906947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography.
    Nordberg A; Lilja A; Lundqvist H; Hartvig P; Amberla K; Viitanen M; Warpman U; Johansson M; Hellström-Lindahl E; Bjurling P
    Neurobiol Aging; 1992; 13(6):747-58. PubMed ID: 1491741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET studies and cholinergic therapy in Alzheimer's disease.
    Nordberg A
    Rev Neurol (Paris); 1999; 155 Suppl 4():S53-63. PubMed ID: 10637939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.
    Kadir A; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2006 Nov; 188(4):509-20. PubMed ID: 16832659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.
    Nordberg A; Lundqvist H; Hartvig P; Lilja A; Långström B
    Alzheimer Dis Assoc Disord; 1995; 9(1):21-7. PubMed ID: 7605618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
    Kadir A; Darreh-Shori T; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2007 May; 191(4):1005-14. PubMed ID: 17310387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET.
    Nordberg A
    Acta Neurol Scand Suppl; 1993; 149():62-5. PubMed ID: 8128843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Alzheimer's disease imaging agents for clinical studies.
    Ryu EK; Chen X
    Front Biosci; 2008 Jan; 13():777-89. PubMed ID: 17981587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
    Poirier J; Delisle MC; Quirion R; Aubert I; Farlow M; Lahiri D; Hui S; Bertrand P; Nalbantoglu J; Gilfix BM; Gauthier S
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12260-4. PubMed ID: 8618881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S; Maskos U
    Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic acetylcholine binding sites in Alzheimer's disease.
    Whitehouse PJ; Martino AM; Antuono PG; Lowenstein PR; Coyle JT; Price DL; Kellar KJ
    Brain Res; 1986 Apr; 371(1):146-51. PubMed ID: 3708340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo.
    Nordberg A; Hartvig P; Lundqvist H; Antoni G; Ulin J; Långström B
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):195-205. PubMed ID: 2789067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology.
    Snowden SG; Ebshiana AA; Hye A; Pletnikova O; O'Brien R; Yang A; Troncoso J; Legido-Quigley C; Thambisetty M
    J Alzheimers Dis; 2019; 72(1):35-43. PubMed ID: 31561368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).
    Olson L; Nordberg A; von Holst H; Bäckman L; Ebendal T; Alafuzoff I; Amberla K; Hartvig P; Herlitz A; Lilja A
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):79-95. PubMed ID: 1540306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatments with tacrine and (-)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat.
    Zhang X; Tian JY; Svensson AL; Gong ZH; Meyerson B; Nordberg A
    J Neural Transm (Vienna); 2002 Mar; 109(3):377-92. PubMed ID: 11956958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.